A Clinical Trial Evaluating TQB2101 in Subjects With Advanced Hematologic Malignancies
A Clinical Trial Evaluating TQB2101 in Subjects With Advanced Hematologic Malignancies
Recruiting · NCT07113925 · Registry updated 2025-08-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Clinical Trial Evaluating TQB2101 in Subjects With Advanced Hematologic Malignancies | Advanced Hematologic Malignancies | Recruiting | Phase 1 | 2025-08-11 | NCT07113925 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | 32 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| The First Affiliated Hospital of Nanchang University | Nanchang | China | 109 |
| The Henan Cancer Hospital | Zhengzhou | China | 1 |
| Zhongshan Hospital, Fudan University | Shanghai | China | 86 |